High incidence of high-risk HPV in benign and malignant lesions of the larynx

International Journal of Oncology

Volumn 39, Issue 1, 2011, Pages 51-59

  Duray, Anaëlle ^a   Descamps, Géraldine ^a   Arafa, Mohammad ^b   Decaestecker, Christine ^c   Remmelink, Myriam ^d   Sirtaine, Nicolas ^e   Ernoux Neufcoeur, Perle ^a   Mutijima, Eugène ^b   Somja, Joan ^b   Depuydt, Christophe E ^g   Delvenne, Philippe ^b   Saussez, Sven ^a,f  

^a UNIVERSITY OF MONS   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c Institute of Pharmacy   (Belgium)

^d ERASME HOSPITAL   (Belgium)

^e Institut Bordet   (Belgium)

^f SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^g Laboratory for Clinical Pathology and Molecular Biology (Labo Lokeren Campus Riatol)   (Belgium)

Author keywords

Benign; Carcinoma; Human papillomavirus; Larynx; PCR; Typing

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR; PROTEIN P16; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; DISEASE FREE INTERVAL; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN TISSUE; LARYNGEAL BENIGN LESION; LARYNGEAL SQUAMOUS CELL CARCINOMA; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; VIRUS GENE; VIRUS LOAD; WART VIRUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHILD; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; INCIDENCE; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53; VIRAL LOAD; YOUNG ADULT;

EID: 79956044565     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1031     Document Type: Article

References (36)

1. Kreimer AR, Clifford GM, Boyle P and Franceschi S: Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14: 467-475, 2005. (Pubitemid 40270113)
2. Aaltonen L-M, Rihkanen H and Vaheri A: Human papillomavirus in larynx. Laryngoscope 112: 700-707, 2002.
3. Gissmann L, Wolnik L, Ikenberg H, Koldovsky U, Schnürch HG and zur Hausen H: Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci USA 80: 560-563, 1983. (Pubitemid 13174644)
4. Almadori G, Cadoni G, Cattani P, et al: Detection of human papillomavirus DNA in laryngeal squamous cell carcinoma by polymerase chain reaction. Eur J Cancer 32: 783-788, 1996.
5. Boscolo-Rizzo P, Da Mosto MC, Fuson R Frayle-Salamanca H, Trevisan R and Del Mistro A: HPV-16 E6 L83V variant in squamous cell carcinomas of the upper aerodigestive tract. J Cancer Res Clin Oncol 135: 559-566, 2009.
6. Gallo A, Degener AM, Pagliuca G, Pierangeli A, Bizzoni F, Greco A and De Vincentiis M: Detection of human papillomavirus and adenovirus in benign and malignant lesions of the larynx. Otolaryngol Head Neck Surg 141: 276-281, 2009.
7. García-Milián R, Hernández H, Panadé L, et al: Detection and typing of human papillomavirus DNA in benign and malignant tumours of laryngeal epithelium. Acta Otolaryngol 118: 754-758, 1998. (Pubitemid 28505615)
8. Koskinen WJ, Brøndbo K, Mellin Dahlstrand H, et al: Alcohol, smoking and human papillomavirus in laryngeal carcinoma: a Nordic prospective multicenter study. J Cancer Res Clin Oncol 133: 673-678, 2007. (Pubitemid 47077059)
9. Lindeberg H and Krogdahl A: Laryngeal cancer and human papillomavirus: HPV is absent in the majority of laryngeal carcinomas. Cancer Lett 146: 9-13, 1999. (Pubitemid 29462551)
10. Rees L, Birchall M, Bailey M and Thomas S: A systematic review of case-control studies of human papillomavirus infection in laryngeal squamous cell carcinoma. Clin Otolaryngol Allied Sci 29: 301-306, 2004. (Pubitemid 38981315)
11. Nunez DA, Astley SM, Lewis FA and Wells M: Human papilloma viruses: a study of their prevalence in the normal larynx. J Laryngol Otol 108: 319-320, 1994. (Pubitemid 24125768)
12. Mammas IN, Sourvinos G, Vakonaki E, Giamarelou P, Michael C and Spandidos DA: Novel human papilloma virus (HPV) genotypes in children with recurrent respiratory papillomatosis. Eur J Pediatr 169: 1017-1021, 2010.
13. Steinberg BM, Topp WC, Schneider PS and Abramson AL: Laryngeal papillomavirus infection during clinical remission. N Engl J Med 308: 1261-1264, 1983. (Pubitemid 13092695)
14. Doyle DJ, Henderson LA, LeJeune FE Jr and Miller RH: Changes in human papillomavirus typing of recurrent respiratory papillomatosis progressing to malignant neoplasm. Arch Otolaryngol Head Neck Surg 120: 1273-1276, 1994. (Pubitemid 24345772)
15. Spandidos DA: Oncogenes and tumor suppressor genes as paradigms in oncogenesis. J BUON 12: S9-S12, 2007.
16. Neufcoeur PE, Arafa M, Delvenne P and Saussez S: Involvement of human papillomavirus in upper aero-digestive tracts cancers. Bull Cancer 96: 941-950, 2009.
17. Almadori G, Cadoni G, Cattani P, et al: Human papillomavirus infection and epidermal growth factor receptor expression in primary laryngeal squamous cell carcinoma. Clin Cancer Res 7: 3988-3993, 2001. (Pubitemid 34044617)
18. Ernoux-Neufcoeur P, Arafa M, Decaestecker C, et al: Combined analysis of HPV DNA, p16, p21 and p53 to predict prognosis in patients with stage IV hypopharyngeal carcinoma. J Cancer Res Clin Oncol 137: 173-181, 2010.
19. Pim D, Collins M and Banks L: Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor. Oncogene 7: 27-32, 2002.
20. Wittekind C, Greene FL, Hutter RVP, Klimpfinger M and Sobin LH: TNM Atlas. In: International Union Against Cancer (UICC). 6th edition. Berlin, 2004.
21. Hyams VJ, Batsakis JG and Michaels L (eds): Tumors of the upper respiratory tract and ear. In: Atlas of Tumor Pathology. Armed Forces Institute of Pathology, Washington, DC, 1988.
22. Depuydt CE, Benoy IH, Bailleul EJ, Vandepitte J, Vereecken AJ and Bogers JJ: Improved endocervical sampling and HPV viral load detection by Cervex-Brush Combi. Cytopathology 17: 374-381, 2006. (Pubitemid 44808532)
23. Depuydt CE, Boulet GA, Horvath CA, Benoy IH, Vereecken AJ and Bogers JJ: Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types. J Cell Mol Med 11: 881-891, 2007. (Pubitemid 47313308)
24. Arbyn M, Benoy I, Simoens C, Bogers J, Beutels B and Depuydt C: Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium. Cancer Epidemiol Biomarkers Prev 18: 321-330, 2009.
25. Saussez S, Decaestecker C, Lorfevre F, et al: Increased expression and altered intracellular distribution of adhesion/growth-regulatory lectins galectins-1 and -7 during tumour progression in hypopha ryngeal and laryngeal squamous cell carcinomas. Histopathology 52: 483-493, 2008. (Pubitemid 351327984)
26. Zaravinos A, Mammas IN, Sourvinos G and Spandidos DA: Molecular detection methods of human papillomavirus (HPV). Int H Biol Markers 24: 215-222, 2009.
27. Clayman GL, Stewart MG, Weber RS, el-Naggar AK and Grimm EA: Human papillomavirus in laryngeal and hypopharyngeal carcinomas. Relationship to survival. Arch Otolaryngol Head Neck Surg 120: 743-748, 1994.
28. Dahlstrand H, Näsman A, Romanitan M, Lindquist D, Ramqvist T and Dalianis T: Human papillomavirus accounts both for increased incidence and better prognosis in tonsillar cancer. Anticancer Res 28: 1133-1138, 2008. (Pubitemid 351578850)
29. D'Souza G, Kreimer AR, Viscidi R et al: Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356: 1944-1956, 2007.
30. Kumar B, Cordell KG, Lee JS, et al: Response to therapy and outcomes in oropharyngeal cancer are associated with biomarkers including human papillomavirus, epidermal growth factor receptor, gender and smoking. Int J Radiat Oncol Biol Phys 69: 109-111, 2007.
31. Rosenquist K, Wennerberg J, Annertz K, Schildt EB, Hansson BG, Bladström A and Andersson G: Recurrence in patients with oral and oropharyngeal squamous cell carcinoma: human papilloma virus and other risk factors. Acta Otolaryngol 127: 980-987, 2007. (Pubitemid 47345810)
32. CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol 16: 859-867, 1996.
33. Psyrri A and Di Maio D: Human papillomavirus and head and neck cancer. Nat Clin Pract Oncol 5: 24-31, 2008. (Pubitemid 351512426)
34. Begum S, Gillison ML, Ansari-Lari MA, Shah K and Westra WH: Detection for papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. Clin Cancer Res 9: 6469-6475, 2003. (Pubitemid 38031835)
35. Cohen MA, Basha SR, Reichenbach DK, Robertson E and Sewell DA: Increased viral load correlates with improved survival in HPV-16-associated tonsil carcinoma patients. Acta Otolaryngol 128: 583-589, 2008. (Pubitemid 351550952)
36. Mammas IN, Sourvinos G, Zaravinos A and Spandidos DA: Vaccination against human papilloma virus (HPV): epidemiological evidence of HPV in non-genital cancers. Pathol Oncol Res (In press).